WITNESSETHLease • April 24th, 1997 • Heska Corp • Iowa
RECITALS:Rights Agreement • April 24th, 1997 • Heska Corp • California
1 EXHIBIT 10.18 INDEMNIFICATION AGREEMENT THIS INDEMNIFICATION AGREEMENT is made and entered into as to this ___th day of _________, 199__ ("Agreement"), by and between Heska Corporation (as successor by name change to Heska Merger Corporation), a...Indemnification Agreement • April 24th, 1997 • Heska Corp • Delaware
FIRST AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT AND SECURITY AGREEMENT This First Amendment, dated as of March 27, 2001, is made by and among HESKA CORPORATION, a Delaware corporation ("Heska"), DIAMOND ANIMAL HEALTH, INC., an Iowa corporation...Credit and Security Agreement • May 10th, 2001 • Heska Corp • Biological products, (no disgnostic substances)
Underwriting AgreementHeska Corp • March 5th, 2021 • In vitro & in vivo diagnostic substances • New York
Heska Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 940,860 shares (the “Underwritten Shares”) of Public Common Stock, par value $0.01 per share, of the Company (the “Common Stock”) and, at the option of the Underwriters, up to an additional 141,129 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
3.750% Convertible Senior Notes due 2026Indenture • September 17th, 2019 • Heska Corp • In vitro & in vivo diagnostic substances • New York
INDENTURE, dated as of September 17, 2019, between HESKA CORPORATION, a Delaware corporation, as issuer (the “Company”, as more fully set forth in Section 1.01), and U.S. BANK NATIONAL ASSOCIATION, a national banking association, as trustee (the “Trustee”, as more fully set forth in Section 1.01).
EXHIBIT 10.4 AMENDMENT NO. 1 TO PRODUCT SUPPLY AND LICENSE AGREEMENT This Amendment is effective as of the date given below and modifies the Product Supply and License Agreement (the Agreement) of May 1, 1995 by and between Paravax, Inc. a corporation...License Agreement • April 24th, 1997 • Heska Corp • Colorado
EXHIBIT 4.2(A) WAIVER AND AMENDMENT --------------------- TO FIRST AMENDED INVESTORS' RIGHTS AGREEMENT -------------------------------------------- THIS WAIVER AND AMENDMENT TO THE FIRST AMENDED INVESTORS' RIGHTS AGREEMENT (the "Agreement") is made as...Rights Agreement • November 16th, 1998 • Heska Corp • Biological products, (no disgnostic substances)
AMENDMENT NO. 4 TO BOVINE VACCINE DISTRIBUTION AGREEMENTSecurity Agreement • August 14th, 2002 • Heska Corp • Biological products, (no disgnostic substances) • Iowa
EXHIBIT 1.1 HESKA CORPORATION (a Delaware corporation) [5,000,000] Shares of Common Stock PURCHASE AGREEMENT Dated: February __, 1998Purchase Agreement • January 23rd, 1998 • Heska Corp • Biological products, (no disgnostic substances) • New York
1. 2 Commission or has become effective upon filing pursuant to Rule 462(c) ("Rule 462(c)") under the Act or, in the case of the additional registration statement, Rule 462(b). For purposes of this Agreement, "Effective Time" with respect to the...Heska Corp • May 30th, 1997 • Biological products, (no disgnostic substances) • New York
VOTING AGREEMENTVoting Agreement • April 24th, 1997 • Heska Corp • California
VESTING This option becomes exercisable in installments, as shown in the Notice of Stock Option Grant. In addition, this option becomes exercisable in full if one of the following events occurs: o Your service as an employee, consultant or director of...Stock Option Agreement • April 24th, 1997 • Heska Corp
1 EXHIBIT 10.13 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT ("Agreement") is entered into by and between DIAMOND ANIMAL HEALTH, INC., an Iowa corporation with its principal office at 2538 S.E. 43rd Street, Des Moines, Iowa ("Company") and LOUIS VAN...Employment Agreement • April 24th, 1997 • Heska Corp • Iowa
2- 3 even date and delivered herewith, the certificate or certificates evidencing the Stock and the duly executed Assignments. Such documents are to be held by the Escrow Agent until delivered pursuant to the terms of such Escrow Agreement. Shares of...Security Agreement • April 24th, 1997 • Heska Corp • California
EXHIBIT 10.28 EMPLOYMENT AGREEMENT -------------------- THIS EMPLOYMENT AGREEMENT ("Agreement") is entered into by and between Heska Corporation, a Delaware corporation with its principal office at 1825 Sharp Point Drive, Fort Collins, Colorado 80525...Employment Agreement • March 29th, 1999 • Heska Corp • Biological products, (no disgnostic substances) • Colorado
AMENDED AND RESTATED EMPLOYMENT AGREEMENT WITH ROBERT B. GRIEVEEmployment Agreement • March 24th, 2000 • Heska Corp • Biological products, (no disgnostic substances) • Colorado
AMENDED AND RESTATED EMPLOYMENT AGREEMENT WITH GIUSEPPE MIOZZARIEmployment Agreement • April 3rd, 2001 • Heska Corp • Biological products, (no disgnostic substances)
WITNESSETH ----------Manufacturing and Supply Agreement • May 15th, 1998 • Heska Corp • Biological products, (no disgnostic substances)
1 EXHIBIT 10.40 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT ("Agreement") is entered into by and between Heska Corporation, a Delaware corporation with its principal office at 1613 Prospect Parkway, Fort Collins, Colorado 80525 ("Company") and DAN...Employment Agreement • August 14th, 2000 • Heska Corp • Biological products, (no disgnostic substances) • Colorado
CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PROTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION] DISTRIBUTION CONTRACTHeska Corp • May 23rd, 2002 • Biological products, (no disgnostic substances)
EXHIBIT 10.35 RIGHT OF FIRST REFUSAL AGREEMENT THIS RIGHT OF FIRST REFUSAL AGREEMENT (the "Agreement") is made and entered into as of the 18th day of August 1998, by and between Heska Corporation, having its principal place of business located at 1825...Right of First Refusal Agreement • March 29th, 1999 • Heska Corp • Biological products, (no disgnostic substances)
CONFIDENTIAL TREATMENT REQUESTED. CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE COMMISSION] AMENDED AND RESTATED DISTRIBUTION AGREEMENTDistribution Agreement • April 1st, 2002 • Heska Corp • Biological products, (no disgnostic substances)
FIRST AMENDMENT TO PRODUCT SUPPLY AGREEMENTProduct Supply Agreement • April 1st, 2002 • Heska Corp • Biological products, (no disgnostic substances)
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 1st, 2020 • Heska Corp • In vitro & in vivo diagnostic substances • Delaware
This Agreement is made pursuant to that certain Series X Preferred Securities Purchase Agreement, dated as of January 12, 2020, as amended by that certain amendment dated March 30 2020, by and among the Company and the Purchasers (the “Purchase Agreement”).
EXHIBIT 10.12 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT ("Agreement") is entered into by and between PARAVAX, INC., a California corporation with its principal office at 2301 Research Boulevard, Suite 110, Fort Collins, Colorado ("Company") and...Employment Agreement • April 24th, 1997 • Heska Corp • Colorado
EMPLOYMENT AGREEMENTEmployment Agreement • February 26th, 2021 • Heska Corp • In vitro & in vivo diagnostic substances • Colorado
This Employment Agreement (the “Agreement”) is made effective on April 9th, 2020 (the “Effective Date”) between Heska Corporation, a Delaware corporation (“Heska”), and Eleanor Baker (“Executive”). Heska and Executive collectively are referred to as the “Parties” and individually as a “Party.”
EXCLUSIVE DISTRIBUTION AGREEMENT JAPAN - BETWEEN -Exclusive Distribution Agreement • March 29th, 1999 • Heska Corp • Biological products, (no disgnostic substances) • Colorado
EXHIBIT 4.5 COMMON STOCK WARRANT PURCHASE AGREEMENTCommon Stock Warrant Purchase Agreement • November 16th, 1998 • Heska Corp • Biological products, (no disgnostic substances) • Delaware
RESIGNATION AGREEMENT AND GENERAL RELEASE This Resignation Agreement and General Release ("Agreement") is entered into between Heska Corporation ("EMPLOYER") and Ronald Hendrick ("EMPLOYEE"). EMPLOYER and EMPLOYEE may be referred to in this Agreement...Resignation Agreement and General Release • August 14th, 2002 • Heska Corp • Biological products, (no disgnostic substances) • Colorado
AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN HESKA CORPORATION AND NANCY WISNEWSKIEmployment Agreement • March 3rd, 2008 • Heska Corp • Biological products, (no disgnostic substances)
This Amendment to Employment Agreement is dated effective as of January 1, 2008 (this “Amendment”) and amends the Employment Agreement dated as of April 15, 2002 (the “Employment Agreement”), between Heska Corporation, a Delaware corporation (“Company”), and Nancy Wisnewski (“Employee”). Unless otherwise defined in herein, all capitalized terms used herein shall have the meaning ascribed to them in the Employment Agreement.
EMPLOYMENT AGREEMENT -------------------- THIS EMPLOYMENT AGREEMENT ("Agreement") is entered into by and between Heska Corporation, a Delaware corporation with its principal office at 1613 Prospect Parkway, Fort Collins, Colorado 80525 ("Company"),...Employment Agreement • March 29th, 1999 • Heska Corp • Biological products, (no disgnostic substances) • Colorado
1 EXHIBIT 10.23 LEASE AGREEMENT OFFICE AND INDUSTRIAL SPACE This Lease Agreement is made and entered into as of the 27th day of June, 1996, by and between GB Ventures ("Landlord"), whose address is 4875 Pearl East Circle, Suite 300, Boulder, CO 80301,...Lease Agreement Office and Industrial Space • April 24th, 1997 • Heska Corp • Colorado
Heska Corporation 2003 Equity Incentive PlanQualified Stock Option Agreement • March 25th, 2015 • Heska Corp • Biological products, (no disgnostic substances)
Tax Treatment This option is intended to be a Non-qualified Stock Option and not an Incentive Stock Option under section 422 of the Internal Revenue Code.
Heska Corporation 2003 Equity Incentive PlanStock Option Agreement • March 6th, 2017 • Heska Corp • Biological products, (no disgnostic substances) • Delaware
